Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sample-size calculation for preclinical dose–response experiments using heterogeneous tumour models

Radiotherapy and Oncology(2021)10.1016/j.radonc.2021.02.032Source: DataRank Database

Sample-size calculation for preclinical dose–response experiments using heterogeneous tumour models is a research paper published in Radiotherapy and Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.73)OA: greenTopics (27)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Nadja Ebert ORCID,Nathalie Borgeaud,Howard D. Thames,Michaël Baumann ORCID,Mechthild Krause ORCID

Live enrichment

PubMed:33667590 PMC:PMC9189616 OpenAlex:https://openalex.org/W3135650586

NCI NIH HHS

Grant: U01 CA220714

National Institutes of Health

FWCI

1.73

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9189616

publisherhttps://api.elsevier.com/content/article/PII:S0167814021060953?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0167814021060953?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.radonc.2021.02.032

Fields of Study

Animal testing and alternativesMathematical Biology Tumor GrowthCarcinogens and Genotoxicity Assessment

MeSH Terms

Squamous Cell Carcinoma of Head and NeckAnimalsCarcinoma, Squamous CellHead and Neck NeoplasmsHumansMonte Carlo MethodProspective StudiesRadiation Oncology

Keywords

MedicineOncologyLogistic regressionRadiation therapyPopulationSample size determinationLung cancerNuclear medicineInternal medicineStatisticsSample sizeDose-response CurvesPre-clinical ResearchTumour ModelsDose-modifying FactorTumour-control Assay

Sustainable Development Goals

SDG 0: Reduced inequalities

Additional file 1 of HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies

10.6084/m9.figshare.26596127.v1figshare

Additional file 1 of HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies

10.6084/m9.figshare.26596127figshare

Additional file 2 of HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies

10.6084/m9.figshare.26596130.v1figshare

Additional file 2 of HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies

10.6084/m9.figshare.26596130figshare